Cited by 60Hemoglobinopathies and Related DisordersMethemoglobinemia and Tumor Lysis SyndromeCOVID-19 Clinical Research Studies

Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype

Open access
Chaturvedi, Shruti, Ghafuri, Djamila L., Glassberg, Jeffrey, Kassim, Adetola A., Rodeghier, Mark, DeBaun, Michael R.·2016·American Journal of Hematology

Abstract

Current definitions of acute chest syndrome (ACS) in sickle cell anemia (SCA) do not account for rapid progression of respiratory compromise. In this two‐center retrospective cohort study, we tested the hypothesis that in children and adults with ACS and respiratory failure (≤24 hours after onset of respiratory symptoms) have a distinct ACS phenotype associated with multiorgan failure when compared to those with ACS that have a more subacute and protracted course. We identified 173 individuals (97 children <20 years and 76 adults ≥20 years) with SCA and at least one episode of ACS. Only one ACS episode was considered per individual. Rapidly progressive ACS occurred in 21% (n = 16) of adults, but only 2.1% (n = 2) of children. Compared to adults without rapidly progressive ACS, adults with rapidly progressive ACS more frequently developed acute kidney injury (68.8% vs. 3.3%, P < 0.001), hepatic dysfunction (75.0% vs. 15.0%, P < 0.001), altered mental status (43.8% vs. 11.7%, P < 0.001), multiorgan failure (93.8% vs. 10%, P < 0.001), and death (6.3% vs. 0%, P = 0.05). Clinical and laboratory covariates that were evaluable on the first day of respiratory symptoms were evaluated to identify predictors of rapidly progressive ACS. On multivariable analysis, decline in platelet count at presentation was the only predictor of rapidly progressive ACS [odds ratio 4.82 (95% CI 1.20–19.39), P = 0.027]. In conclusion, rapidly progressive ACS is a distinct phenotype that occurs more frequently in adults, is preceded by thrombocytopenia, and is associated with multiorgan failure. Am. J. Hematol. 91:1185–1190, 2016. © 2016 Wiley Periodicals, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajh.24539

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated initial platelet count and dramatic drops during vaso-occlusive crisis have been found to portend a poor prognosis in acute chest syndrome.

    “Elevated initial platelet count and dramatic drops during VOC have been found to portend a poor prognosis in ACS (29, 208, 219).”

    From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [29]

    The Discussion (page unavailable) associates thrombocytopenia with poor ACS outcomes, and the results identify a decrease in platelet count at presentation as a predictor of rapidly progressive ACS. The paper does not establish that an elevated initial platelet count predicts poor prognosis; its platelet-drop finding concerns presentation with ACS, not specifically drops during vaso-occlusive crisis. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chaturvedi, S., Ghafuri, D. L., Glassberg, J., Kassim, A. A., Rodeghier, M., & DeBaun, M. R.
Affiliations
  • Vanderbilt University (US)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Mount Sinai Hospital (US)
  • Rodeghier Consultants Chicago Illinois
  • Vanderbilt University Medical Center (US)
Corresponding author
DeBaun, Michael R.
Venue
American Journal of Hematology
Publisher
Wiley
Published
2016-10-03
Volume
91
Issue
12
Pages
1185-1190
ISSN
  • 0361-8609 (ISSN-L)
  • 1096-8652
OpenAlex
W2511476568
Cited by
60
References
36
Citations by year
2026: 6 · 2025: 7 · 2024: 9 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 7 · 2019: 8 · 2018: 5 · 2017: 3 · 2015: 1
FWCI
3.87
Type
journal article
Language
en
Open access
Locations
  • American Journal of Hematology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Burroughs Wellcome Foundation
  • American Society of Hematology
  • NCATS/NIH (UL1 TR000445)
Topics
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Methemoglobinemia and Tumor Lysis Syndrome
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
acute chest syndrome, sickle cell disease, phenotypes, respiratory failure, multiple organ failure, acute kidney injury, liver dysfunction, thrombocytopenia, platelet count decline, mortality, children and adults
MeSH terms
Adolescent, Adult, Anemia, Sickle Cell, Child, Child, Preschool, Female, Humans, Male, Multiple Organ Failure, Phenotype, Respiratory Insufficiency, Retrospective Studies, Time Factors, Cohort Studies, Disease Progression, Young Adult, Acute Chest Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review